Adipokines are active molecules with pleiotropic effects produced by adipose tissue and
involved in obesity-related metabolic and cardiovascular diseases. Arterial stiffness, which is …

Omega-3 fatty acids have emerged as a new option for controlling the residual risk for
cardiovascular disease (CVD) in the statin era after a clinical trial (REDUCE-IT) reported …

Background Statins are potential drugs for decreasing risk of atherosclerotic cardiovascular
complications in type 2 diabetic (T2D) patients. Purpose To examine the efficacy of both …

Objectives: Heart disease is the most common cause of death in patients with nonalcoholic
fatty liver disease (NAFLD). Emerging data have shown that NAFLD may affect subclinical …

Background Plasma omentin levels have been shown to be associated with circulating
adiponectin concentrations and cardiometabolic disease-related outcomes. In this study, we …

Background Metabolic syndrome (syndrome X) is the name for a group of risk factors that
raises your risk for heart disease and other health problems, such as diabetes and stroke …

A prevalência de obesidade e insuficiência cardíaca com fração de ejeção preservada
(ICFEP) aumenta significativamente em mulheres na pós-menopausa. Embora a obesidade …

The prevalence of obesity and heart failure with preserved ejection fraction (HFpEF)
increases significantly in postmenopausal women. Although obesity is a risk factor for left …

Снижение смерти и кардиоваскулярных событий у пациентов с фибрилляцией
предсердий (ФП) и ожирением остается актуальной проблемой. На базе ГБОУ ВО …